The ingredient is marketed as a safer, more effective alternative to caffeine.
TSI Group (Missoula, MT) has gained exclusive distribution rights for Enfinity Energy LLC’s Enfinity ingredient, which is said to be a safer, more effective alternative to caffeine. According to the companies, “Enfinity functions more consistently than caffeine, leading to fewer side effects, greater enjoyability, improved mood, and a more focused mindset.”
Enfinity is made of paraxanthine. As the companies explain, “Roughly 70% of caffeine is metabolized as paraxanthine, which is caffeine’s efficacious compound. Enfinity bypasses the side effect–riddled middlemen (theophylline, theobromine, and caffeine itself) and goes straight to work delivering newfound energy without jitters, anxiety, crashes, or sleep problems.”
Enfinity’s benefits include providing energy, focus, and “wakeful clarity”; enhancing mood and well-being; acting as a neuroprotective cognitive accelerant; improving reaction time and reducing mental errors; and increasing caloric expenditure and thermogenesis.
The ingredient is also said to be easier to formulate with compared to caffeine because its taste is less bitter. It is suited for use in gummies, ready-to-drink beverages, energy drinks, fat burners, nootropics, and preworkout powders at a daily dose ranging from 100-300 mg.
The ingredient, which is supported by 23 filed patents, four human clinical studies, and more preclinical work, is now set to market globally under TSI’s distribution. Said TSI Group President Larry Kolb, “Enfinity is becoming very popular. It is a well-developed ingredient that is disrupting the industry with real innovation that has not been seen in years.”
Kaneka Nutrients to unveil new consumer research on menopausal women at Vitafoods Europe 2024
April 26th 2024The company will reveal the results of the research that is based on live feedback from 200 menopausal women who took 200 mg per day of Kaneka Ubiquinol over two-months, monitored the effects, and recorded their observations.
Rousselot to showcase new collagen peptide research and targeted solutions at Vitafoods Europe 2024
April 25th 2024The company will be highlighting new research that demonstrates the ability of its Peptan collagen peptide brand to support sleep quality, reduce gastrointestinal discomfort, and enhance skin health, including density, hydration, and elasticity.